This topic contains a solution. Click here to go to the answer

Author Question: The main reason(s) firms in a competitive market cannot earn positive profits in the long run ... (Read 82 times)

jc611

  • Hero Member
  • *****
  • Posts: 552
The main reason(s) firms in a competitive market cannot earn positive profits in the long run is(are)
 a. assets can quickly move in and out of the industry when demand fluctuates
 b. an increase in demand leads to entry of firms which absorb the extra demand
 c. a decrease in demand leads to exit of firms from the market such that there is no surplus
  d. all of the above

Question 2

In a sealed-bid first price auction, if you notice that your competition is stronger, you should
 a. Shade your bid more
 b. Shade your bid less
 c. Bid more aggressively
  d. Both B&C



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

meryzewe

  • Sr. Member
  • ****
  • Posts: 346
Answer to Question 1

d

Answer to Question 2

d




jc611

  • Member
  • Posts: 552
Reply 2 on: Jul 1, 2018
YES! Correct, THANKS for helping me on my review


coreycathey

  • Member
  • Posts: 333
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

In women, pharmacodynamic differences include increased sensitivity to (and increased effectiveness of) beta-blockers, opioids, selective serotonin reuptake inhibitors, and typical antipsychotics.

Did you know?

Parkinson's disease is both chronic and progressive. This means that it persists over a long period of time and that its symptoms grow worse over time.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

Complications of influenza include: bacterial pneumonia, ear and sinus infections, dehydration, and worsening of chronic conditions such as asthma, congestive heart failure, or diabetes.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library